Sunidhi Securities & Finance acquired 10 lakh equity shares of Pricol at Rs94.05 per share on the NSE.
Ramesh Krishnamurthy, CEO of Vivimed Labs Ltd said, "Successful launch of Famotidine is a demonstration of Vivimed's COMO capability to
On Sensex, Vivimed closed at the upper circuit of Rs29.70 per piece higher by 4.95%.
The tablets will be manufactured and marketed under Vivimeds brand name Favulous across India.
On Sensex, Vivimed Labs closed at Rs19.75 per piece up by 15.5%.
Vivimed is a niche Specialty Chemicals and Pharmaceuticals company.
The GMP approval extension also includes 5 new product registrations.
Chlorpheniramine is an antihistamine used to relieve symptoms of allergy, hay fever, and the common cold.
Consequent to the above transaction, VSCPL ceased to be the wholly owned subsidiary of the company.
It received approvals for 3 ophthalmic products from its state of the art sterile Ophthalmic facility and 3 oral liquid suspension prod
Per Order for ETF & Mutual Funds Brokerage
Per Order for Delivery, Intraday, F&O, Currency & Commodity